GeoVax Labs Inc./$GOVX
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
Ticker
$GOVX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
17
ISIN
US3736786068
Website
GeoVax Labs Inc. Metrics
BasicAdvanced
$6.6M
-
-$3.23
3.44
-
Price and volume
Market cap
$6.6M
Beta
3.44
52-week high
$1.89
52-week low
$0.43
Average daily volume
1.8M
Financial strength
Interest coverage (TTM)
-1,153.98%
Profitability
EBITDA (TTM)
-24.567
Gross margin (TTM)
-340.71%
Net profit margin (TTM)
-438.16%
Operating margin (TTM)
-441.13%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
-915.19%
Return on equity (TTM)
-78,814.57%
Valuation
Price to revenue (TTM)
0.651
Price to book
842.28
Price to tangible book (TTM)
842.28
Growth
Earnings per share change (TTM)
-77.09%
3-year revenue growth (CAGR)
150.29%
10-year revenue growth (CAGR)
21.03%
3-year earnings per share growth (CAGR)
-58.30%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GeoVax Labs Inc. stock?
GeoVax Labs Inc. (GOVX) has a market cap of $6.6M as of July 05, 2025.
What is the P/E ratio for GeoVax Labs Inc. stock?
The price to earnings (P/E) ratio for GeoVax Labs Inc. (GOVX) stock is 0 as of July 05, 2025.
Does GeoVax Labs Inc. stock pay dividends?
No, GeoVax Labs Inc. (GOVX) stock does not pay dividends to its shareholders as of July 05, 2025.
When is the next GeoVax Labs Inc. dividend payment date?
GeoVax Labs Inc. (GOVX) stock does not pay dividends to its shareholders.
What is the beta indicator for GeoVax Labs Inc.?
GeoVax Labs Inc. (GOVX) has a beta rating of 3.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.